<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7054296/results/search/disease/results.xml">
  <result pre="ICTV Coronaviridae Study Group on February 12, 2020), causes severe" exact="respiratory" post="illness1 and has been spreading around the world rapidly.2"/>
  <result pre="treatment of the deadly disease. However, current antiviral drugs have" exact="limited" post="effects on 2019-nCov (SARS-CoV-2). Although Gileadâ€™s NUC (nucleoside) inhibitor,"/>
  <result pre="different countries and a flexible CRISPR/Cas13d strategy for treating 2019-nCov(SARS-CoV-2)" exact="virus infection" post="and countering its evolution. a, b Sequence analysis of"/>
  <result pre="countries and a flexible CRISPR/Cas13d strategy for treating 2019-nCov(SARS-CoV-2) virus" exact="infection" post="and countering its evolution. a, b Sequence analysis of"/>
  <result pre="b Sequence analysis of 2019-nCov(SARS-CoV-2) virus RNA genome with available" exact="complete" post="sequences from 19 infected patients in China, USA and"/>
  <result pre="array for treatment of patients with 2019-nCov (SARS-CoV-2) infection. ITR" exact="inverted" post="terminal repeats. Our group has implemented a flexible and"/>
  <result pre="rapid novel approach for the treatment and prevention of RNA" exact="virus infection." post="Future studies determining the safety and efficacy of this"/>
 </snippets>
</snippetsTree>
